Coya Therapeutics (COYA) Profit After Tax (2022 - 2026)

Coya Therapeutics (COYA) has 5 years of Profit After Tax data on file, last reported at -$7.2 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 1.37% year-over-year to -$7.2 million; the trailing twelve-month figure through Mar 2026 stood at -$21.1 million (down 23.29% YoY), and the FY2025 full-year result was -$21.2 million, down 42.64% from the prior year.
• Profit After Tax fell to -$7.2 million in Q1 2026, from -$5.7 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $1.3 million in Q4 2023 to a low of -$7.3 million in Q1 2025.
• A 5-year average of -$3.7 million and a median of -$3.4 million in 2022 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax surged 140.74% in 2023 and plunged 330.32% in 2024, its largest moves.
• Tracing COYA's Profit After Tax over 5 years: stood at -$3.1 million in 2022, then jumped by 140.74% to $1.3 million in 2023, then sank by 330.32% to -$2.9 million in 2024, then tumbled by 95.78% to -$5.7 million in 2025, then dropped by 26.25% to -$7.2 million in 2026.
• Business Quant data shows COYA's Profit After Tax at -$7.2 million in Q1 2026, -$5.7 million in Q4 2025, and -$2.1 million in Q3 2025.